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ABSTRACT
Purpose: To estimate the prevalence of external punctal stenosis (EPS) in the 
elderly population and investigate associated factors. 
Methods: A total of 278 patients ≥65 years of age were evaluated for evidence 
of EPS from January to July 2016. Associated systemic, ocular, demographic, 
and lifestyle factors were investigated. Multiple logistic regression analyses 
were applied to evaluate the factors related to having EPS. P values <0.05 were 
considered statistically significant. 
Results: The prevalence of EPS in this study population was 63.3%, with a mean 
age of 70.67 ± 7.85 (65-92 years). The ocular factor that was most commonly 
related to EPS was chronic blepharitis (48.9%). EPS was also associated with 
taking glaucoma medications (95% CI, 0.08-0.96, p=0.043), smoking history (95% 
CI, 0.13-0.84, p=0.021), ectropion (95% CI, 0.004-0.26, p=0.001), complaints of 
tearing (95% CI, 1.11-3.52, p=0.02), and outdoor occupational activity (95% CI, 
3.42-9.97, p<0.05). 
Conclusions: EPS is more common in elderly patients than in the general popu-
lation. Outdoor occupational activity, taking antiglaucomatous medications, 
ectropion, and smoking are significantly associated with EPS. In addition, 
surgical treatment decisions should be made after complete evaluation and 
interviewing the patients.
Keywords: Lacrimal apparatus; Lacrimal duct obstruction; Blepharitis; Dry eye 
syndromes; Aged; Turkey/epidemiology
RESUMO
Objetivo: Estimar a prevalência de estenose externa do ponto lacrimal (EEPL) na po-
pulação idosa e investigar os fatores associados. 
Métodos: Foram avaliados 278 pacientes ≥65 anos com estenose externa do ponto 
lacrimal de janeiro a julho de 2016. Todos os fatores sistêmicos, oculares, demográ-
ficos e de estilo de vida associados foram investigados. Foram utilizadas análises de 
regressão logística múltipla para avaliar os fatores relacionados a estenose externa do 
ponto lacrimal, valores de p<0,05 foram considerados estatisticamente significativos. 
Resultados: A prevalência de estenose externa do ponto lacrimal foi de 63,3%, com 
idade média de 70,67 ± 7,85 (65-92 anos). O fator ocular mais relacionado com 
estenose externa do ponto lacrimal foi blefarite crônica. (IC de 95%, 0,08-0,96, 
p=0,043), história de tabagismo (IC 95%, 0,13-0,84, p=0,021), ectrópio (IC 95%, 0,004-
0,26, p=0,001), queixa de lacrimejamento (95% IC, 1,11-3,52, p=0,02) e atividade 
ocupacional ao ar livre (IC 95%, 3,42-9,97, p<0,05). 
Conclusão: A estenose externa do ponto lacrimal é um distúrbio mais comum em 
pacientes idosos do que na população em geral. Atividade ocupacional ao ar livre, 
medicação antiglaucomatosa, ectrópio e tabagismo foram significativamente associados 
com estenose externa do ponto lacrimal. A decisão sobre tratamento cirúrgico deve 
ser dada após a avaliação completas dos fatores associados em cada paciente.
Descritores: Aparelho lacrimal; Obstrução dos ductos lacrimais; Blefarite; Síndromes 
do olho seco; Idoso; Turquia/epidemiologia
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INTRODUCTION
External punctal stenosis (EPS) is a common disorder of the 
punctum. Regardless of the cause of EPS, this condition, which 
can be congenital or acquired, can cause epiphora as a result of 
blockage of the lacrimal passage. The acquired form can originate 
from topical or systemic medication use, various infections, lid 
malposition, or different forms of trauma and tumors(1-3). Changes 
caused by aging are also a risk factor for EPS(4). The prevalence of 
EPS increases with age, and has been reported to be between 17.3% 
and 54.3%(5,6).
Because of the lack of research in this field, we aimed to evaluate 
the prevalence of EPS and associated factors in elderly patients in 
Turkey.
METHODS
This cross-sectional study was performed in Konya, Turkey. 
Patients who were older than 65 years were recruited from the 
patient population that visited our general ophthalmology clinic 
from January to July 2016. The participants were questioned about 
basic demographic data, complaints of epiphora, systemic disease, 
glaucoma therapy, smoking history (patients were categorized accor-
ding to their smoking habits into three groups as follows: (1) current 
smokers (people who smoke any tobacco product occasionally), (2) 
nonsmokers, and (3) ex-smokers (people who had smoked regularly 
in the past and had quit smoking at least 1 year before the study), and 
occupational history (grouped as outdoor or indoor activity).
A slit-lamp biomicroscopy was used to evaluate the external 
punctum. EPS was visually graded according to the criteria used by 
Kashkouli et al.(7). All patients with EPS had a grade 1 (severe punctal 
stenosis) or grade 2 (less severe punctal stenosis) punctal opening 
(Table 1). In addition, the presence of pterygium, eyelid malposi-
tions (ectropion, entropium, trichiasis, and distichiasis), chronic da -
cryocystitis, cataract, and age-related macular degeneration were 
also documented. Chronic dacryocystitis was revealed by performing 
nasolacrimal duct irrigation. A dilated biomicroscopic examination 
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Table 1. Grading of different external punctal opening sizes
Grade Clinical findings
Methods of inserting A #00 
bowman probe
0 No papilla and punctum 
(punctal atresia)
Need to create a papilla by surgery
1 Papilla is covered by a 
membrane (exudative or true 
membrane) or fibrosis, and is 
difficult to recognize
Need a no. 25 needle, followed by 
a punctal finder and then standard 
punctum dilator
2 Smaller than normal size, but 
recognizable
Need a punctal finder and then a 
standard punctum dilator
3 Normal Need a regular punctum dilator
4 Small slit (<2 mm) No need for intervention
5 Large slit (≥2 mm) No need for intervention
Table 2. Demographic, lifestyle, ocular, and systemic factors associa-
ted with external punctal stenosis
EPS (+) EPS (-) ORa
Age (years) 72.77 ± 7.8 67.03 ± 6.54 0.89 (3.93-7.54)
Sex
Male 88 (65.2%) 047 (34.8%) 0.95 (0.56-1.63)
Female 88 (61.5%) 055 (38.5%) Reference
Complaints of tearing
Yes 121 (69.5%) 053 (30.5%) 1.97 (1.12-3.52)
No 055 (52.9%) 049 (47.1%) Reference
Dry eye
Yes 017 (50.0%) 017 (50.0%) 0.72 (0.33-1.56)
No 159 (65.2%) 085 (34.8%) Reference
Blepharitis
Yes 080 (58.8%) 056 (41.2%) 1.00 (0.58-1.72)
No 096 (67.6%) 046 (32.4%) Reference
Pterygium
Yes 006 (40.0%) 009 (60.0%) 0.37 (0.11-1.23)
No 170 (64.6%) 093 (35.4%) Reference
Ectropion
Yes 033 (97.1%) 001 (2.90%) 0.03 (0.004-0.26)
No 143 (58.6%) 101(41.4%) Reference
Hypertension
Yes 067 (59.8%) 045 (40.2%) 0.71 (0.41-1.24)
No 109 (65.7%) 057 (34.3%) Reference
Diabetes mellitus
Yes 043 (58.1%) 031 (41.9%) 0.57 (0.31-1.05)
No 133 (65.2%) 071 (34.8%) Reference
Congestive heart failure
Yes 005 (50.0%) 005 (50.0%) 0.55 (0.12-2.40)
No 171 (63.8%) 097 (36.2%) Reference
COPD
Yes 006 (75%) 002 (25.0%) 2.12 (0.34-13.09)
No 170 (63%) 100 (37.0%) Reference
Glaucoma drops
Yes 020 (83.3%) 004 (16.7%) 3.33 (1.04-10.61)
No 156 (61.4%) 098 (38.6%) Reference
Occupation
Outdoor 134 (78.8%) 036 (21.2%) 0.73 (0.41-1.29)
Indoor 042 (38.9%) 066 (61.1%) Reference
Smoking
Smoker 022 (52.4%) 020 (47.6%) 0.14 (0.05-0.45)
Non-smoker 121 (62.7%) 072 (37.3%) 0.41 (0.18-0.93)
Ex-smoker 033 (76.7%) 010 (23.3%) Reference
EPS= external punctal stenosis; COPD= chronic obstructive pulmonary disease.
of the fundus with a +78 diopters lens was performed to detect 
age-related macular degeneration.
Suspected dry eye was also evaluated with tear film breakup 
time (BUT), fluorescein and rose bengal staining, and Schirmer’s 
test. The BUT was also measured by touching the inferotemporal 
bulbar conjunctiva with a fluorescein sodium strip wetted with a 
preservative-free isotonic saline. Patients were asked to blink, and 
the precorneal tear film was examined under blue light illumination 
using a slit-lamp biomicroscope. The mean value of three measu-
rements was recorded. The BUT was considered low when it was 
less than 10 seconds. The corneal surface was then examined for 
fluorescein staining, and its presence or absence was recorded. The 
cases were labeled as asymptomatic if they did not complain of 
epiphora and their tear meniscus height was less than 2 mm. The 
patients were labeled as having dry eye if they had a BUT less than 
10 s and positive corneal staining with fluorescein. Schirmer’s test 
was performed in both eyes. Five minutes after the instillation of 
one drop of oxybuprocaine hydrochloride 0.4%, the inferior fornix 
was gently blotted, and a precalibrated standard filter strip was 
placed in the lower temporal fornix for 5 min. During this time, 
the participants were instructed to look slightly upward and blink 
normally. After removing the strip, the length of the strip that was 
wet was measured. The test result was considered positive if this 
measurement was ≤5 mm.
This study was approved by Baskent University Institutional Review 
Board and Ethics Committee (Project no: 94603339-604.01.02/2131) 
and supported by the Baskent University Research Fund. Informed 
consent was obtained from all participants. The study adhered to the 
tenets of the Declaration of Helsinki.
StatiStical analySiS
Statistical data were analyzed using SPSS version 21.0 (IBM Corp., 
Armonk, NY, USA). Values were expressed as the mean ± standard 
deviation. The chi-square test with 95% confidence intervals (CIs) and 
Fisher’s exact test were used to assess the effects of sex, systemic 
disease, topical or systemic medication, smoking, and occupational 
activity. Multiple logistic regression analyses were used to evaluate 
the independent factors related to having EPS. P values <0.05 were 
considered statistically significant.
RESULTS
A total of 278 patients were recruited, with a mean age of 70.67 
± 7.85 (65-92 years). The prevalence of EPS was 63.3% (176/278) 
among this elderly population visiting our general eye clinic for 
routine ophthalmologic examination. One hundred thirty-five of 
the patients were men (48.6%) and 143 were women (51.4%). One 
hundred twelve (40.3%) patients had bilateral EPS. The presence of 
epiphora was consistent with the EPS ratio (p=0.004). No sex domi-
nance was observed for EPS (p=0.45).
Chronic blepharitis was found in 45.5% (80/176) of the patients 
with EPS (95% CI, 0.58-1.72, p=0.13), and this was the most common 
ocular factor associated with EPS. The associations between the 
presence of EPS and other demographic, occupational, ocular, and 
systemic factors are presented in table 2.
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Univariate and multivariate logistic regression analyses were 
used to identify the independent predictors of EPS (Table 3). Com-
plaints of tearing (95% CI, 1.11-3.52, p=0.02), ectropion (95% CI, 
0.004-0.26, p=0.001), glaucoma drop usage (95% CI, 0.08-0.96, 
p=0.043), smoking (95% CI, 0.13-0.84, p=0.021), and outdoor occu-
pational activity (95% CI, 3.42-9.97, p<0.05) were significantly asso-
ciated with EPS according to the results of the multivariate logistic 
regression analysis. In contrast, we did not find significant associa-
tions between EPS and smoking or outdoor occupational activity.
DISCUSSION
To date, this is the first study to evaluate EPS in elderly patients 
only. The prevalence of EPS was found to be 63.3% in this patient 
population. EPS is a common cause of epiphora, and recent studies 
have reported a wide range in the prevalence of the latter, from 8% 
to 54.3%(5,6,8,9). Similarly, we had found a prevalence of EPS of 25.8% 
in our previous study(10). All of these previous studies reported a 
positive correlation between the prevalence of EPS and increasing 
age. This association is thought to be the result of changes caused 
by aging and fibrosing of the tissue surrounding the punctum(4). 
Studies that evaluated the histopathologic changes in EPS speci-
mens reported that fibrosis is the most prevalent finding, followed 
by chronic inflammation(11,12). The higher prevalence of EPS in our 
study can be explained according to the findings reported in these 
previous studies.
Previous studies reported female dominancy in EPS(7,13), and 
suggested that postmenopausal hormonal changes may be respon-
sible for this sex difference; however, other reports did not show sex 
differences(5,6). These authors suggested that this lack of sex diffe-
rence could be related to differing sampling methods used in these 
studies. Similarly, we did not find any sex difference in our study. 
Our sample group was recruited from patients attending a general 
ophthalmology clinic, and we believe that this is an ideal method 
of recruitment to minimize bias.
Chronic blepharitis was diagnosed in 45.5% of our patients, and 
it was the most commonly related factor to EPS. However, we did 
not find any significant association between blepharitis and EPS. 
Conversely, the authors of previous studies showed that the most 
common underlying factor for EPS was blepharitis(5-7); similarly, no 
significant association was found between EPS and blepharitis in 
these studies. However, the authors suggested that chronic blepha-
ritis predisposes individuals to EPS on the basis of the inflammatory 
and cicatricial changes. Consistent with these reports, recent studies 
have showed that chronic inflammation is the most common finding 
in EPS specimens(11,12). It is clear that the chronic inflammatory process 
resulting from chronic blepharitis plays an important role, even if not 
completely, in the development of EPS.
We also evaluated the association between EPS and dry eye, 
pterygium, and other levels of lacrimal pathway stenosis; however, 
we did not find any significant relationships. On the other hand, 
previous studies have reported an association between EPS and 
nasolacrimal ductal stenosis; topical medication use, systemic che-
motherapy, trachoma, and cicatrizing diseases of the conjunctiva 
are thought to be responsible for this relationship(13-16). However, 
Kashkouli et al. did not find any association between EPS and lacri-
mal pathway stenosis(7). Although an association between EPS and 
pinguecula was found in a recent study, the authors did not find any 
relationship between EPS and pterygium, as we did in our study(5). 
They suggested that aging and sun exposure could be the common 
etiologic factors for these diseases.
Eyelid malposition, as seen in ectropion, may cause punctal ste-
nosis, possibly due to underuse of an external punctum unopposed 
to the tear meniscus, or perhaps secondary to local inflammation(17). 
Damasceno et al. revealed a decrease in elastic fibers in the pretarsal 
orbicularis oculi muscle, in the tarsal stroma, and in the eyelid skin 
in patients suffering from age-related involutional ectropion and 
entropion; these changes might have caused the fibrotic changes 
in the EPS specimens observed in previous research(18). In our study, 
18.8% (33/143) of the patients with EPS had ectropion (p=0.002). 
Previous studies that studied EPS did not show any association 
between these two situations (i.e.; EPS and ectropion). Presumably, 
the authors felt that this relationship did not need to be evaluated 
because of the already well-known and strong association between 
these pathologies. However, the difference in treatment between EPS 
and ectropion means that it is important to show the relationship 
between these diseases.
Long-term treatment with several topical antiglaucoma agents 
has also been associated with punctal stenosis(15). In addition, the 
conjunctiva and Tenon’s capsule of the patients receiving long-term 
latanoprost therapy exhibit inflammatory changes(19). However, this 
association has not been shown in population-based EPS studies 
until now. In our study group, EPS was significantly more prevalent 
in patients taking glaucoma medication (p=0.033). Nonetheless, it is 
important to take into consideration the lack of discrimination of the 
type of glaucoma drops and the medication period.
There are two main types of risk factors: intrinsic and extrinsic. 
Extrinsic factors include parameters such as alcohol use, chronic 
exposure to sunlight, smoking, and nutrition deficit. The most impor-
tant parameter, contributing to 80% of skin aging, appears to be sun 
exposure. Ultraviolet A rays induce the formation of reactive oxygen 
species that readily react with membrane lipids and amino acids, and 
are suspected of playing a substantial role in skin photoaging(21). Skin 
photoaging can lead to fibrotic changes in punctal tissue and EPS. 
Therefore, we evaluated and found a significant association between 
outdoor occupational activity and EPS (95% CI, 3.42-9.97, p<0.05). 
Agricultural workers constituted the majority of our study group. 
Similarly, Viso et al. found a significant relationship between these 
parameters and EPS(5).
Previous studies that included histopathologic analysis have 
revealed that 10-15% of EPS specimens show squamous metapla-
sia(11,12). Squamous metaplasia is known to be an epithelial response 
to chronic irritant exposure, and is typically seen in the airways of 
smokers. Therefore, we evaluated the effect of smoking on EPS, and 
found that current smokers have a significantly greater EPS ratio 
than non-smokers and ex-smokers (95% CI, 0.13-0.84, p=0.021). If 
we had had a chance to assess the histopathology of these patients, 
we suspect that we might have found a high rate of squamous 
metaplasia. Conversely, a recent study did not find this difference 
in smokers compared to non-smokers(5).
Dry eye is a common ocular surface disease in elderly pa-
tients(22). The effectiveness of punctal occlusion in dry eye patients 
is reportedly comparable to that of other treatment modalities(23). 
In our study, complaints of epiphora were significantly associated 
with the presence of EPS. However, 31.3% (55/176) of the patients 
with EPS had no complaints of epiphora, although increased tear 
meniscus was found after punctal occlusion in previous research(24).
In addition, 92.7% (51/55) of these patients had no dry eye findings. 
These results indicate that EPS may help protect against dry eye in 
Table 3. Multivariate logistic regression analysis of potential associa-
tions with external punctal stenosis
OR 95% CI p
Complaints of tearing 1.970 1.110-3.52 0.020
Ectropion 0.032 0.004-0.26 0.001
Glaucoma drops 0.290 0.080-0.96 0.043
Smoking 0.140 0.050-0.45 0.001
Outdoor occupation 0.330 0.190-0.55 0.000
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elderly patients. According to the data, we suggest that surgical in-
tervention for EPS in elderly patients should not be overly promoted 
to avoid impairment of this suspected protective mechanism.
In conclusion, to the best of our knowledge, this was the first 
study to evaluate EPS in elderly patients. We showed that its pre-
valence was higher in this group than in the general population. 
Chronic inflammation, antiglaucomatous medication use, ectropion, 
smoking, and sun exposure as a result of outdoor occupation activity 
are significant etiologic factors in the development of EPS. However, 
further studies with a large sample size supported by histopathologic 
analysis are needed in future to verify these associations.
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